Skip to main content
The Oncologist logoLink to The Oncologist
. 2013 Aug;18(8):971. doi: 10.1634/theoncologist.2012-0478errata

Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer

Axel S Merseburger, Joaquim Bellmunt, Cheryl Jenkins, Chris Parker, John M Fitzpatrick, on behalf of the European Treatment Practices Group
PMCID: PMC3755936

The Oncologist 2013;18:558-567; doi:10.1634/theoncologist.2012-0478

Due to a copyediting error, on page 559, the IMPACT study was erroneously defined and should read “Immunotherapy for Prostate Adenocarcinoma Treatment Study.” The authors and the publisher thank Drs. Christos Mikropoulos and Rosalind Eeles for bringing this to our attention.


Articles from The Oncologist are provided here courtesy of Oxford University Press

RESOURCES